Realyze Intelligence has developed a suite of tools to facilitate clinical trial matching & data abstraction – together these tools can:
- Accelerate screening & matching of patients to oncology clinical trials
- Provide auto-abstraction for Real World Data needs (registry, research, etc)
- Identify care pathways and pathway adherence
The Realyze solution enables clinical oncology research sites to increase enrollment, target more diverse populations and turbocharge clinical research capabilities using existing resources. Our goal is to be a force-multiplier for existing oncology clinical trial & research teams.
The Realyze platform leverages a combination of AI, LLMs and clinically guided expert models to analyze EHR data in real time, instantly matching patients to clinical trials. Additionally, the solution captures and makes available all the key clinical data from the unstructured notes to allow it to be imported back into the EMR, improving research and other clinical uses.
-- Realyze has provided a 5x increase in patient matching for oncology clinical trials, including expanding the target locations and demographics for the identified populations.
-- Realyze has processed and analyzed over 3 million patient records and well over 10 million individual medical documents across 36 different source systems/EMRs.
-- Clinical teams using the Realyze intelligence solution have seen a reduction in trial screening time from 1-2 hours to under a minute per patient.
-- The Realyze solution augments existing workflows and integrates the data back into EMRs & CTMSs.
-- The Realyze solution acts as a force-multiplier for your existing team – freeing them from the drudgery of screening & abstraction.
-- The Realyze platform has been used to identify patients to optimize value-based care programs, registry entry, care coordination, & research.
-- Realyze collaborates w. leading health systems such as Memorial Sloan Kettering Cancer Center, OneOncology & UPMC.
Did you know that less than 15% of oncology clinical trial participants are minorities?
In a joint research statement, ASCO & ACCC made a recommendation that *every* cancer patient be proactively screened for clinical trials to help combat the complex causes of inequity. Read more : https://lnkd.in/gWTuisGB
Sound daunting or unfeasible? We can help.
The Realyze Intelligence platform drives inclusivity in clinical trials by enabling screening at scale with existing resources. Further, we can capture hard-to-parse social determinants of health to drive future research and inclusive datasets.
Join us in building a better oncology future. Clinical Trials For All#DiversityInResearch#ClinicalInclusionMatters#CloseTheCareGap#PrecisionOncology#AIPrecisionOncology#ClinicalTrialsForAll#AIOncology#RealyzeIntelligence
In his "Ctrl+Alt+Cure - Rebooting Cancer Care" substack - AI in Precision Oncology expert Douglas Flora, MD, FACCC, LSSBB perfectly describes the complexities of precision oncology at scale, “I see these challenges magnified across entire health systems. It's like watching thousands of dedicated healthcare professionals trying to navigate rush-hour traffic without real-time updates—each fighting through bottlenecks, searching for shortcuts, hoping they're making the best decisions with limited information.”
Read more of his insights :: https://lnkd.in/gEnFupQa
To put it simply : if you're in the proverbial traffic jam - Realyze can help.
Our tools enhance & augment human, clinical expertise. We empower clinicians with data-driven insights for smarter, faster decision-making so they can navigate the complex & ever changing clinic environment. Whether it is personalized care for an individual patient or deep real-world data analysis to power the next precision medicine breakthrough - we can help.
#AIinHealthcare#MedicalAI#FutureOfMedicine#HealthTech#RealyzeIntelligence#AIinPrecisionOncology
Announcing the 2025 CancerX Accelerator Cohort!
We are thrilled to introduce the 14 pioneering startups selected for the 2025 CancerX Accelerator, a national innovation platform designed to accelerate digital solutions in the fight against cancer. These game-changing companies are tackling critical challenges in clinical research, diagnostics, treatment, clinical operations, and patient/caregiver experiences—all with the goal of reducing cancer death rates and improving lives.
These innovative companies will work closely with our Accelerator Champions (and others) to fast-track their solutions and create lasting impact.
We’re excited to see how these startups drive change, and we can’t wait to follow their journey as they work to transform the future of cancer care.
Stay tuned for updates and be part of the movement to revolutionize oncology with #CancerXAccelerator!
#Innovation#CancerCare#DigitalHealth#Oncology#Startups#HealthTech#CancerMoonshot#Constellation
Last year, excitement about AI dominated the healthcare industry, with companies teaming up with technologists to roll out numerous pilots. In 2025, experts say that providers will begin to ask: Does this actually work?
“Is it alleviating some of the burdens of administrative work? Is it taking away some of the mundane, repetitive tasks that they’re often bogged down with day to day?”
Susanna Vogel has the story via Healthcare Dive: https://bit.ly/40Slbtz | #AdminEfficiencies#BurnoutPrevention#ClinicalWorkflows#HealthData
Clinical Trials For All is partnering with patients, caregivers, patient advocates, health science companies, and advocacy groups to shine a light on the importance and benefits of clinical trial participation while enabling greater inclusion in research.
Join us in spreading the word about clinical trials to our friends, family, colleagues, and future patients.
Clinical Trials For All is a noncommercial initiative to increase global clinical trial participation by educating patients and caregivers about the opportunities and advantages of research as care. Learn more: https://bit.ly/4k0RRsn | #ClinicalTrialsForAll#ClinicalResearch#EducateEngageEmpower
HIMSS 25 is right around the corner, andwe’re excited to step into the future of healthcare in Vegas!
#HIMSS25 is a leading conference uniting healthcare leaders, innovators, and changemakers to drive the future of healthcare technology and patient care. We're excited to be part of this dynamic gathering, showcasing how Carta Healthcare transforms data into actionable insights to empower providers and improve patient outcomes.
If you'll be at HIMSS, we'd love to connect! Reach out to schedule a meeting with Greg Miller while in Vegas. Let's collaborate and discuss how we can drive meaningful change in the healthcare industry together. https://bit.ly/4aew389 | #ActionableInsights#HealthData#ClinicalDataAbstraction#EmpoweredProviders#ImprovedOutcomes
Have you registered yet for the 24th PMWC - Precision Medicine World Conference (PMWC 2025)? The PMWC 2025 Silicon Valley Conference takes place in the Santa Clara Convention Center and is co-hosted by Stanford University Medicine and University of California, San Francisco, both current Carta healthcare customers.
We’re excited to attend this informative session during PMWC 2025, “Understanding the whole patient story, in real time”:
🎙 Presenter: Kathryn Doornbos, Ph.D., Director, Clinical Partnerships, Realyze Intelligence, a Carta Healthcare company.
🗓 When/Where: Showcase Track (S1) on Day 2: 2/6/25, 9:45 am – 10:00 am PT
Attend this session to learn how the Realyze Intelligence platform unlocks clinical insights from the patient record to drive precision medicine. Hear how their partners are already using these insights to accelerate clinical trial screening at scale, build powerful clinico-genomic databases, monitor nudge, clinical pathway adherence, and turbocharge complex, RWD data dependent research pursuits.
Learn more about Doornbos’ presentation and we look forward to seeing you there: https://bit.ly/4fXcXEP | #PMWC25#ClinicalInsights#PrecisionMedicine#PrecisionMedicineWorldConference#PatientStory#RealTimeData#RealWorldDataTal Behar
